Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease

The metabolomic and proteomic basis of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) is poorly understood, and the relationships between systemic abnormalities in metabolism and AD/MCI pathogenesis is unclear. This study compared the metabolomic and proteomic signature of plasma from...

Descripción completa

Detalles Bibliográficos
Autores principales: François, Maxime, Karpe, Avinash V., Liu, Jian-Wei, Beale, David J., Hor, Maryam, Hecker, Jane, Faunt, Jeff, Maddison, John, Johns, Sally, Doecke, James D., Rose, Stephen, Leifert, Wayne R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610280/
https://www.ncbi.nlm.nih.gov/pubmed/36295851
http://dx.doi.org/10.3390/metabo12100949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610280/
https://www.ncbi.nlm.nih.gov/pubmed/36295851
http://dx.doi.org/10.3390/metabo12100949

Ejemplares similares